#Sars

Megan O'Driscoll

meganodris

Our analysis on age-specific mortality and immunity patterns of SARS-CoV-2 has now been published @nature. We look at COVID-19 death data in 45 countries and 22 serostudies to investigate the

Prof Francois Balloux

BallouxFrancois

I felt it may be helpful to provide an update on the new #COVID19 lineages in the UK and in SA that might both be more contagious than any #SARSCoV2

Dr. Angela Rasmussen

angie_rasmussen

Hard to underscore the importance of this beautiful study by @eguia_rachel and colleagues (see @jbloom_lab's great thread).The bottom line is that coronavirus "reinfections" don't occur b/c we don't mount durable

Trevor Bedford

trvrb

At this point, the countries with most genomic data to analyze spread of the variant virus belonging to https://cov-lineages.org B.1.1.7 lineage or @nextstrain clade 20I/501Y.V1 are the UK, Denmark and

Alina Chan

Ayjchan

Some have reached out to me to ask about the recent preprint by Institut Pasteur International Network on the SARS2-like bat virus that was found in North East Cambodia in

Jesse Shapiro

bjesseshapiro

In case anyone wanted *more* evidence that kids can be important vectors of SARS-CoV-2 transmission, check out our preprint of an emergency childcare centre in Quebec led by @INSPQ with

Billy Bostickson 🏴👁&👁 🆓

BillyBostickson

1. TMEM41B - SARS-COV-2 - EAST ASIANS?TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replicationhttps://www.news-medical.net/news/20201210/Study-TMEM41B-transmembrane-protein-is-a-critical-factor-for-SARS-CoV-2-replicatio

Yardley Yeadon

MichaelYeadon3

This is a good high level discussion on variants and immune responses & importantly also faces head on the possibility that some people are injured or even killed by vaccines

Dr Clare Craig

ClareCraigPath

China is trolling us with this and Nature should be embarrassed at having published it:https://www.nature.com/articles/s41467-020-19802-w It claims 10M people were tested in the last two weeks of June in Wuhan.

Jonathan Mesiano-Crookston @/#COVIDisAirborne

jmcrookston

Asia has been there for a while.Then CDC half way.Germany accepted.WHO will get there but has holdups on its guidance committee.Now Canada taking steps.Be on the leading edge of science.Sign

Shannon Young

SYoungReports

For example, this timeline slide. Dec 28: Flight from Amsterdam to Mexico City. Dec 29: Flight to Matamoros.GAP: Where did he spend the night of Dec. 28th? How did he

Matt Raybould

mijr12

1/5 Growing evidence that E484 variants (e.g. SA variant) can largely escape evenly strongly neutralising serum from first wave (in past week, by Andreano et al. https://www.biorxiv.org/content/10.1101/2020.12.28.424451v1 and by Greaney

Anderson Brito

AndersonBrito_

The past two months have been quite imtense: heavy workload with genomic surveillance of SARS-CoV-2 variants.Beyond my amazing collaborators @YaleSPH, I’d like to give a shout-out to those leading key

Michael Lin, PhD-MD

michaelzlin

WHO learned diverse SARSCoV2 sequences were found in Wuhan in 12/2019, suggesting 1000s were already infected.I've wondered if the reason why the virus appeared well adapted to humans by 12/2019

ɪᴀɴ ᴍ. ᴍᴀᴄᴋᴀʏ, ᴘʜᴅ 🦠🤧🧬🥼🦟🧻

MackayIM

Convalescent plasma treatment for SARS-CoV-2infection-most make antibody (Ab) , most Ab neutralises (NAb) SARS-CoV-2 and most people retain measurable levels after 50 dayshttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.2

Mark F. McCarty

markfmccarty

@Covid19Crusher @jpkiekens @Ian56789 @gummibear737 How to Crush COVID-19 with Early Treatment SARS-CoV-2 gets into cells either via endosomes, or directly thru the plasma membrane. This requires fusion of the viral

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.